Catalán, D. (2016). B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and Fc gamma RIIb, which are modulated by anti-tumor necrosis factor therapy.
Citación Chicago StyleCatalán, D. B Cells From Rheumatoid Arthritis Patients Show Important Alterations in the Expression of CD86 and Fc Gamma RIIb, Which Are Modulated By Anti-tumor Necrosis Factor Therapy. 2016.
Cita MLACatalán, D. B Cells From Rheumatoid Arthritis Patients Show Important Alterations in the Expression of CD86 and Fc Gamma RIIb, Which Are Modulated By Anti-tumor Necrosis Factor Therapy. 2016.